Statins and monocytes [4]

Lancet

Volumn 353, Issue 9169, 1999, Pages 2070-

  Ikeda, U ^a   Shimada, K ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUINDOSTATIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PRAVASTATIN; STATIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOKINE; HYPOCHOLESTEROLEMIC AGENT;

ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; LETTER; MONOCYTE; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; METABOLISM;

ANTICHOLESTEREMIC AGENTS; CELL LINE; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MONOCYTES; PRAVASTATIN;

EID: 0033549204     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)77885-5     Document Type: Letter

References (3)

1. RS Rosenson CC Tangney LC Casey Inhibition of proinflammatory cytokine production by pravastatin Lancet 353 1999 983 984
2. CG Ericsson A Hamsten J Nilsson L Grip B Svane U de-Faire Angiographic assessment of effects of benzefibrate on progression of coronary artery disease in young male postinfarction patients Lancet 347 1996 849 853
3. B Staels W Koenig A Habib Activation of human aortic smooth-muscle cells is inhibited by PRARα but not by PPARγ activators Nature 393 1998 790 793